Page 118 - Memoria FEHH - SEHH 2017

GRUPO ESPAÑOL DE LINFOMAS Y TRASPLANTE AUTÓLOGO DE MÉDULA ÓSEA (GELTAMO)
MEMORIA ANUAL 2017
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
TJ, Montes-Moreno S, González-Barca E, Caballero D, Martín A; from the GELTAMO Spanish Collaborative Group. A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: a multicenter, retrospective analysis by the Spanish GELTAMO group. Am J Hematol. 2018 Jul;93(7):867-73. PMID: 9658143.
Comunicaciones en congresos internacionales
• Gutiérrez A, Bento L, Montalbán C, Díaz-López A, Garrote H, Freue J, López L, Oña R, Martín Moreno AM, López- Guillermo A, Dlouhy I, Rovira J, Rodríguez M, Sánchez JM, Baile M, Martín A, Novelli S, Sancho JM, García O, Salar A, Bastos M, Rodríguez-Salazar M, Fernández R, Domínguez JF, Queizan JA, González de Villambrosia S, Córdoba R, Abraira V, García JF, Rodríguez Era J. Evaluation of the MD Anderson Tumor Score and Their Tumor Re- lated Prognostic Variables in the Rituximab. ASH 59th Annual Meeting. Atlanta, GA, December 9-12, 2017. Blood. 2017;130:827. Abstract 827. Oral presentation.
• Montalbán C, Díaz-López A, Martín A, Baile M, Sánchez JM, Sancho JM, García O, Novelli S, Monter Rovira A, Salar A, Bastos M, Gutiérrez A, Córdoba R, Arquero T, González de Villambrosia S, Barranco G, de Oña R, Hong A, Casanova M, López-Guillermo A, Rodríguez-Salazar MJ, Domínguez JF, Fernández R, Queizan JA, Rodríguez J, Abraira V, García JF. Geltamo-IPI Distinctly Identifies a Very High Risk Group in Difuse Large B-Cell Lymphoma (DLBCL) of Non B-Germinal-Center Origin Treated with Chemo-Immunotherapy. ASH 59th Annual Meeting. Atlanta, GA, December 9-12, 2017. Blood. 2017;130(suppl. 1):abstract 1559. Poster presentation.
• López-Parra M, Bellei M, Rambaldi A, Novelli S, Panizo C, Martelli M, Dlouhy I, Bastos M, Gutiérrez A, Sancho JM, Ramírez Sánchez MJ, Moraleda JM, Carrillo-Cruz E, Jiménez Ubieto AI, Jarque I, Vitolo U, de las Heras N, Arranz R, López Jiménez J, Montalbán C, Pascual M, Corradini P, Bobillo S, García-Torres E, Spina M, Rossi G, Manni M, Caba- llero D, Federico M, Martín A. Efficacy of Autologous Stem Cell Transplantation in First Complete Remission in Patients with Peripheral T-Cell Lymphoma: A Multicenter Geltamo/FIL Study. ASH 59th Annual Meeting. Atlanta, GA, December 9-12, 2017. Blood. 2017;130:2008. Abstract 2008. Poster presentation.
• Baile M, Rodríguez G, Dlouhy I, Sancho JM, Jarque I, González-Barca E, Salar A, Espeso M, Grande C, Bergua JM, Montes S, Redondo A, Enjuagues A, Campo E, López-Guillermo A, Caballero D, Martín A. Lenalidomide in combina- tion with R-ESHAP (LR-ESHAP) in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO. EBMT 44th Annual Meeting. Lisbon, Portugal. Oral Session 1 – Lymphoma.
• Redondo AM, Valcárcel D, González AP, Suárez-Lledó M, Bello JL, Canales M, Gayoso J, Conde E, Jarque I, Del Campo R, Arranz R, Terol MJ, Rifón JJ, Rodríguez MJ, Ramírez MJ, Castro N, Sánchez A, López-Jiménez J, Briones J, López A, Palomera L, Baile M, Caballero D, Martín A. Bendamustine as an alternative to BCNU as conditioning regimen for autologous stem cell transplantation in patients with aggressive lymphoma: results phase 2 study from GELTAMO. EBMT 44th Annual Meeting. Lisbon, Portugal. Poster session.
• Baile M, Barrena S, Sancho J, Grande C, Fernández R, Batlle A, Peñarrubia M, Peñalver F, Hernández-Rivas J, Gui- nea J, Pérez J, Vidriales M, Martín A. Assessment of bone marrow infiltration and minimal residual disease by multidimensional flow cytometry in patients with diffuse large B-cell lymphoma. 23rd Congress of the European Hematology Association. Stockholm, Sweden, June 14-17, 2018. HemaSphere. 2018;2(S1):461. PS1027.
• Jiménez Ubieto A, Grande C, Caballero D, Yáñez L, Novelli S, Hernández-García M, Manzanares M, Arranz R, Ferrei- ro J, Bobillo S, Mercadal S, Galego A, López-Jiménez J, Moraleda J, Vallejo C, Albo C, Pérez-Ceballos E, Marrero C, Magnano L, Palomera L, Jarque I, Martín A, Coria E, López-Guillermo A, Salar A, Lahuerta J. Autologous stem cell transplantation may potentially abrogate the negative prognostic effect of early relapse after chemo or
118